Dimerix (ASX:DXB) FCF Margin %: -1,410.68% (As of Dec. 2025)


ASX:DXB Dimerix Ltd ASX:DXB
32 GF Score
Price A$0.20
! 3 Warning Signs
View Full Analysis

What is Dimerix FCF Margin %?

Dimerix ASX:DXB +2.56% 32 FCF Margin % is -1,410.68% as of Dec. 2025. GuruFocus rates ASX:DXB with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 960 Biotechnology companies, Dimerix ranks better than 98.96% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Dimerix's Free Cash Flow for the six months ended in Dec. 2025 was A$-29.86 Mil. Dimerix's Revenue for the six months ended in Dec. 2025 was A$2.12 Mil. Therefore, Dimerix's FCF Margin % for the quarter that ended in Dec. 2025 was -1,410.68%.

As of today, Dimerix's current FCF Yield % is 9.52%.

The historical rank and industry rank for Dimerix's FCF Margin % or its related term are showing as below:

ASX:DXB' s FCF Margin % Range Over the Past 10 Years
Min: -1724.82   Med: -513.11   Max: 698.6
Current: 154.07

During the past 13 years, the highest FCF Margin % of Dimerix was 698.60%. The lowest was -1724.82%. And the median was -513.11%.

ASX:DXB's FCF Margin % is ranked better than
98.96% of 960 companies
in the Biotechnology industry
Industry Median: -85.21 vs ASX:DXB: 154.07

Dimerix FCF Margin % Related Terms

Dimerix FCF Margin % Historical Data

* Premium members only.

The historical data trend for Dimerix's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dimerix FCF Margin % Chart

Dimerix Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -1,724.82 698.60

Dimerix Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,159.40 -6,037.23 -787.11 779.20 -1,410.68

ASX:DXB vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Dimerix's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dimerix FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dimerix's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Dimerix's FCF Margin % falls into.


ASX:DXB
32GF Score
Dimerix Ltd ASX:DXB
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dimerix FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Dimerix's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=39.031/5.587
=698.60 %

Dimerix's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-29.864/2.117
=-1,410.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -1,410.68% mean?
Dimerix (ASX:DXB) has a FCF Margin % of -1,410.68% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dimerix and its competitors. According to the industry distribution chart, Dimerix ranks #10 out of 960 companies in the Biotechnology industry, placing it in the top 1%.
Is Dimerix's FCF Margin % too high?
Dimerix's current FCF Margin % is -1,410.68%. Based on the distribution chart, Dimerix ranks #10 out of 960 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Dimerix has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Dimerix's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Dimerix ranks #10 out of 960 companies for FCF Margin %. This places Dimerix in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dimerix and its competitors. Dimerix's current FCF Margin % is -1,410.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimerix stock overvalued right now?
Dimerix (ASX:DXB) has a current FCF Margin % of -1,410.68%. The current FCF Margin % is -1,410.68%. Dimerix's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Dimerix (ASX:DXB), the current FCF Margin % is -1,410.68% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dimerix Business Description

Address 425 Smith Street, Fitzroy, VIC, AUS, 3065
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD, as well as the proprietary ReceptorHIT assay technology. It pursues new product concepts and applies deep scientific knowledge to the discovery of products from early-stage development through to commercialisation. Dimerix products will target multiple territories. The Group has only operated in one Segment, being investment in research and development of biopharmaceutical drugs.
32GF Score

Get the complete analysis for ASX:DXB

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.20
Price